Owl Creek Asset Management’s NRX Pharmaceuticals NRXP Stock Holding History

Owl Creek Asset Management’s Portfolio NRXP Stock Details NRXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,000	Closed	-$37K	–	250
2022 Q3	$37K	Hold	5,000	–	–	﹤0.01%	198
2022 Q2	$30K	Hold	5,000	–	–	﹤0.01%	257
2022 Q1	$123K	Hold	5,000	–	–	0.01%	247
2021 Q4	$239K	Hold	5,000	–	–	0.02%	255
2021 Q3	$464K	Sell	5,000 -25,000	-83%	-$3.25M	0.02%	188
2021 Q2	$3.4M	Buy	+30,000	New	+$7.92M	0.16%	66

Other funds holding NRXP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCBWMS

Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HSA

HBK Sorce Advisory Erie, Pennsylvania $5.05B AUM 16.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Owl Creek Asset Management's NRXP Position: Q4 2022 in Review

Owl Creek Asset Management sold out of NRX Pharmaceuticals (NRXP) in Q4 2022, closing a stake of 5,000 shares — an estimated $37K sold.

Owl Creek Asset Management first reported a position in NRXP in Q2 2021 and held it in 6 quarters. The position peaked at $3.4M in Q2 2021. 33 funds tracked by Wall St. Rank hold NRXP as of Q4 2022.

Owl Creek Asset Management reported no remaining NRX Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Owl Creek Asset Management sold 5,000 NRX Pharmaceuticals shares in Q4 2022, an estimated $37K.
Owl Creek Asset Management first reported a position in NRX Pharmaceuticals in Q2 2021 and held it in 6 quarters.
Owl Creek Asset Management's NRX Pharmaceuticals position peaked at $3.4M in Q2 2021.
33 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q4 2022.

Based on Owl Creek Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.